Your browser doesn't support javascript.
loading
Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature.
Contreras, Josefina Longeri; Ladino, Mabel A; Aránguiz, Katherine; Mendez, Gonzalo P; Coban-Akdemir, Zeynep; Yuan, Bo; Gibbs, Richard A; Burrage, Lindsay C; Lupski, James R; Chinn, Ivan K; Vogel, Tiphanie P; Orange, Jordan S; Poli, M Cecilia.
Afiliação
  • Contreras JL; Facultad de Medicina Universidad del Desarrollo-Clínica Alemana, Santiago, Chile.
  • Ladino MA; Universidad de Chile, Reumatóloga Pediátrica Hospital San Juan de Dios, Santiago, Chile.
  • Aránguiz K; Unidad de Inmunología y Reumatología Hospital Luis Calvo Mackenna, Providencia, Chile.
  • Mendez GP; Patológo Renal, Departamento de Anatomía Patológica, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Coban-Akdemir Z; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
  • Yuan B; Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States.
  • Gibbs RA; Department of Laboratories, Seattle Children's Hospital, Seattle, WA, United States.
  • Burrage LC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
  • Lupski JR; Sequencing Center, Baylor College of Medicine, Houston, TX, United States.
  • Chinn IK; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
  • Vogel TP; Texas Children's Hospital, Houston, TX, United States.
  • Orange JS; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
  • Poli MC; Sequencing Center, Baylor College of Medicine, Houston, TX, United States.
Front Pediatr ; 9: 673957, 2021.
Article em En | MEDLINE | ID: mdl-34095032
ABSTRACT
Lysinuric protein intolerance (LPI) is an inborn error of metabolism caused by defective transport of cationic amino acids in epithelial cells of intestines, kidneys and other tissues as well as non-epithelial cells including macrophages. LPI is caused by biallelic, pathogenic variants in SLC7A7. The clinical phenotype of LPI includes failure to thrive and multi-system disease including hematologic, neurologic, pulmonary and renal manifestations. Individual presentations are extremely variable, often leading to misdiagnosis or delayed diagnosis. Here we describe a patient that clinically presented with immune dysregulation in the setting of early-onset systemic lupus erythematosus (SLE), including renal involvement, in whom an LPI diagnosis was suspected post-mortem based on exome sequencing analysis. A review of the literature was performed to provide an overview of the clinical spectrum and immune mechanisms involved in this disease. The precise mechanism by which ineffective amino acid transport triggers systemic inflammatory features is not yet understood. However, LPI should be considered in the differential diagnosis of early-onset SLE, particularly in the absence of response to immunosuppressive therapy.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article